• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard U.S. Momentum Factor ETF (NY:VFMO)

201.30 +2.13 (+1.07%)
Official Closing Price Updated: 8:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,229
Open 200.01
Bid (Size) 198.38 (1,300)
Ask (Size) 202.00 (1,000)
Prev. Close 199.17
Today's Range 200.01 - 202.22
52wk Range 128.58 - 202.22
Shares Outstanding N/A
Dividend Yield 0.70%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious? ↗
December 19, 2025
The FDA approved 5 mg, 10 mg, 15 mg, 20 mg Myqorzo tablets for the treatment of symptomatic obstructive hypertrophic cardiomyopathy. 
Via Stocktwits
Lyft Draws Investor Attention After Wedbush Downgrades Stock Amid Autonomous Vehicle Risks ↗
December 19, 2025
Via Stocktwits

Performance

YTD
+3.4%
+3.4%
1 Month
+1.1%
+1.1%
3 Month
+3.0%
+3.0%
6 Month
+15.7%
+15.7%
1 Year
+24.1%
+24.1%

More News

Read More
News headline image
Why Is CorMedix Stock Rising Today? ↗
December 18, 2025
Via Stocktwits
News headline image
Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit ↗
December 17, 2025
Via Stocktwits
News headline image
JPMorgan Investment Banking Chief Plans Exit After 45 Years As Bank Ramps Up AI And Braces For $105B Costs: Report ↗
December 15, 2025
Via Stocktwits
Topics Artificial Intelligence Retirement
Toll Brothers Stock Slides After-Hours On Q4 Miss And Softer Delivery Forecast ↗
December 08, 2025
Via Stocktwits
American Eagle's Gen Z Playbook Is Working — Sydney Sweeney And Travis Kelce Might Only Be The Opening Act ↗
December 03, 2025
Via Stocktwits
Uber In Talks With Getir To Expand Delivery Services In Turkey: Report ↗
November 06, 2025
Via Stocktwits
News headline image
Palantir CIO Jim Siders To Depart After 12 Years To Head Thrive Capital’s New IT Services Business ↗
December 15, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
ServiceNow Stock Is Down 5% Today — What’s Weighing On The Shares? ↗
December 15, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
Broadcom Stock Jumps After Hours As Strong Q4 And Surging AI Chip Demand Drive Upbeat Outlook ↗
December 11, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
Rhythm Pharmaceuticals Stock Rises After Positive Study Data For Setmelanotide In Treating Genetic Disorder ↗
December 11, 2025
Via Stocktwits
BHVN Stock Tumbled A Whopping 44% Today – What Did The FDA Letter Say? ↗
November 05, 2025
Via Stocktwits
News headline image
Micron To Stop Selling Crucial Consumer Products As It Heightens Focus On Larger Customers ↗
December 03, 2025
Via Stocktwits
News headline image
Abercrombie & Fitch Catches Retail Attention After Barclays Raises Price Target On Hollister Momentum ↗
November 28, 2025
Via Stocktwits
News headline image
Why ANF Stock Is Soaring Before The Bell Today? ↗
November 25, 2025
Via Stocktwits
News headline image
Micron Stock Draws Investor Attention Following A Price Target Boost From UBS ↗
November 20, 2025
Via Stocktwits
News headline image
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial ↗
November 19, 2025
Via Stocktwits
News headline image
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results ↗
November 18, 2025
Via Stocktwits
News headline image
Why Did Scholar Rock Soar 26% Today? ↗
November 14, 2025
Via Stocktwits
Topics Earnings
News headline image
Uber COO Says Robotaxi Tech Is Largely Ready But Hardware Costs Are Still Too High ↗
November 12, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance ↗
November 12, 2025
Via Stocktwits
Topics Earnings
News headline image
2 Vanguard ETFs to Buy Hand Over Fist and 1 to Avoid ↗
November 12, 2025
Via The Motley Fool
Topics ETFs
News headline image
Fiserv Shares Plunge 44% In Record One-Day Drop As Company Gets Wall Street Downgrades On Leadership Changes, Forecast Cuts ↗
October 29, 2025
Via Stocktwits
News headline image
BridgeBio Shares Second Positive Late-Stage Study Result In A Week – Calcium Disorder Drug Trial Yields Positive Results ↗
October 29, 2025
Via Stocktwits

Frequently Asked Questions

Is Vanguard U.S. Momentum Factor ETF publicly traded?
Yes, Vanguard U.S. Momentum Factor ETF is publicly traded.
What exchange does Vanguard U.S. Momentum Factor ETF trade on?
Vanguard U.S. Momentum Factor ETF trades on the New York Stock Exchange
What is the ticker symbol for Vanguard U.S. Momentum Factor ETF?
The ticker symbol for Vanguard U.S. Momentum Factor ETF is VFMO on the New York Stock Exchange
What is the current price of Vanguard U.S. Momentum Factor ETF?
The current price of Vanguard U.S. Momentum Factor ETF is 201.30
When was Vanguard U.S. Momentum Factor ETF last traded?
The last trade of Vanguard U.S. Momentum Factor ETF was at 01/09/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap